Gland Pharma Limited (NSE:GLAND)
India
· Delayed Price · Currency is INR 1,433.20
+3.10 (0.22%)
May 13, 2025, 3:29 PM IST
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 236.13 billion as of May 13, 2025. Its market cap has decreased by -19.32% in one year.
Market Cap
236.13B
Enterprise Value
211.19B
Revenue
57.29B
Ranking
n/a
PE Ratio
33.52
Stock Price
1,433.20
Market Cap Chart
Since November 20, 2020, Gland Pharma's market cap has decreased from 297.10B to 236.13B, a decrease of -20.52%. That is a compound annual growth rate of -5.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 235.62B | -19.63% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | 382.04B | 28.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,045.76B |
| Divi's Laboratories | 1,577.41B |
| Cipla | 1,220.83B |
| Mankind Pharma | 1,031.45B |
| Apollo Hospitals Enterprise | 995.85B |
| Zydus Lifesciences | 890.37B |
| Aurobindo Pharma | 700.39B |
| Alkem Laboratories | 600.28B |